Title
The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury
Date Issued
01 November 2018
Access level
open access
Resource Type
journal article
Author(s)
Pontificia Universidad Javeriana
Publisher(s)
Humana Press Inc.
Abstract
Previous studies have shown that estradiol reduces reactive gliosis after a stab wound injury in the cerebral cortex. Since the therapeutic use of estradiol is limited by its peripheral hormonal effects, it is of interest to determine whether synthetic estrogenic compounds with tissue-specific actions regulate reactive gliosis. Tibolone is a synthetic steroid that is widely used for the treatment of climacteric symptoms and/or the prevention of osteoporosis. In this study, we have assessed the effect of tibolone on reactive gliosis in the cerebral cortex after a stab wound brain injury in ovariectomized adult female mice. By 7 days after brain injury, tibolone reduced the number of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes, the number of ionized calcium binding adaptor molecule 1 (Iba1) immunoreactive microglia, and the number of microglial cells with a reactive phenotype in comparison to vehicle-injected animals. These effects on gliosis were associated with a reduction in neuronal loss in the proximity to the wound, suggesting that tibolone exerts beneficial homeostatic actions in the cerebral cortex after an acute brain injury.
Start page
8651
End page
8667
Volume
55
Issue
11
Language
English
OCDE Knowledge area
Bioquímica, Biología molecular
Neurociencias
Subjects
Scopus EID
2-s2.0-85044466438
PubMed ID
Source
Molecular Neurobiology
ISSN of the container
08937648
Sponsor(s)
We thank Elisa Baides Rosell for excellent technical assistance. All procedures involving animals were approved by the CSIC institutional animal use and care committee and by the Comunidad de Madrid (PROEX 134/17) and followed the European Parliament and Council Directive (2010/63/EU) and the Spanish regulation (Ley 6/2013, 11th June) on the protection of animals for experimental use. The authors declare that they have no conflict of interest.
Funding This work was supported by grants from Ministerio de Economía, Industria y Competitividad (MINECO), Spain (grant numbers BFU2014–51836-C2-1-R and BFU2017-82754-R), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), and Instituto de Salud Carlos III, Madrid, Spain and Fondos Feder.
Sources of information:
Directorio de Producción Científica
Scopus